<?xml version="1.0"?>

<document>
	<title>Pseudomonas aeruginosa infection in cystic fibrosis.  Relative
   prevalence of antibodies in serum against cathodic and anodic
   migrating P. aeruginosa antigens determined by immunoelectrophoretic
   methods.</title>

	<author>Holby-N.</author>

	<source>Acta-Pathol-Microbiol-Scand [C]. 1977 Apr. 85(2). P 149-52.</source>

	<abstract>Sera from 119 patients with cystic fibrosis were examined for
   precipitating antibodies against anodic migrating P. aeruginosa
   antigens by means of crossed immunoelectrophoresis. The presence of
   precipitins against cathodic migrating P. aeruginosa antigens was
   investigated by means of classical immunoelectrophoresis. Thirty-six
   per cent of the sera contained precipitins against both anodic and
   cathodic antigens, 20% contained only precipitins against anodic
   antigens, none contained only precipitins against cathodic antigens,
   and 44% had no demonstrable P. aeurginosa precipitins. The amount of
   extra information obtained by combining the results of classical
   immunoelectrophoresis with the results of crossed
   immunoelectrophoresis was small.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: co</majorsubject>
	<majorsubject>PSEUDOMONAS-INFECTIONS: co</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>ANTIBODIES-BACTERIAL: an</minorsubject>
	<minorsubject>ANTIGENIC-DETERMINANTS</minorsubject>
	<minorsubject>ANTIGENS-BACTERIAL: an</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>COMPARATIVE-STUDY</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: im</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</minorsubject>
	<minorsubject>INFANT</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PSEUDOMONAS-AERUGINOSA: im</minorsubject>
	<minorsubject>PSEUDOMONAS-INFECTIONS: im</minorsubject>

	<reference>001   AXELSEN NH            SCAND J IMMUNOL                  5   177 976</reference>
	<reference>002   BURNS MW              LANCET                           1   270 968</reference>
	<reference>003   BURNS MW              MED J AUST                       2   697 972</reference>
	<reference>004   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>005   DOGGETT RG            INFECT IMMUN                     6   628 972</reference>
	<reference>006   GRABAR P              BIOCHIM BIOPHYS ACTA            10   193 953</reference>
	<reference>007   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>008   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   321 975</reference>
	<reference>009   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   83   433 975</reference>
	<reference>010   HOIBY N               SCAND J IMMUNOL SUPPL 2          4   187 975</reference>
	<reference>011   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   84   372 976</reference>
	<reference>013   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   85   142 977</reference>
	<reference>014   MAY JR                ARCH DIS CHILD                  47   908 972</reference>
	<reference>015   WEEKE B               SCAND J IMMUNOL SUPPL 1          2    15 973</reference>

	<citation>1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>2   NEGASSI K             CLIN EXP IMMUNOL                38   135 979</citation>
	<citation>3   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   329 979</citation>
	<citation>4   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (B)   87   337 979</citation>
	<citation>5   HOIBY N               ACTA PATH MICROBIOL SCAND (C)   89   185 981</citation>
	<citation>6   EMMETT M              J IMMUNOL METH                  50  R 65 982</citation>
	<citation>7   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>

</document>
